Belgium's fast-growing Genae has expanded into Germany, opening up an outpost in Frankfurt to tap one of Europe's largest medical device markets.
The Antwerp-headquartered CRO specializes in trials for medical devices and biologics, and its latest expansion will help it cash in on a booming market, the company said. There are about 480 medical device trials currently running in Germany, accounting for about 20% of Europe's total, according to Genae.
"The German offices will create 12 to 15 new jobs in the next three years," CEO Bart Segers said in a statement. "We continue to expand our operations in Europe and beyond to serve our customers better by providing local anchoring and cultural compatibility, while maintaining a global focus on research."
Genae has been steadily raising its profile since opening a U.S. branch in 2011, and the company hopes an October partnership with Yale University will further expand visibility. Genae teamed up with the Yale Cardiovascular Research Group, the school's in-house clinical service provider, to share and subcontract monitoring, regulatory, safety, core laboratory, data management and statistical analysis services for medical device clients.
Since its foundation in 2005, Genae has expanded to include four outposts in Europe and the U.S.
- read the statement